---
figid: PMC4014913__jdi-2-170-g2
figlink: /pmc/articles/PMC4014913/figure/f2/
number: Figure 2
caption: Metabolic pathways of fatty acid (FA) and triacylglycerol (TAG) synthesis,
  and mechanisms by which lipid intermediates affect hepatic insulin sensitivity.
  Excess lipid intermediates in the TAG biosynthetic pathway, such as diacylglycerol
  (DAG), phosphatidic acid (PA) and lysophosphatidic acid (LPA), cause insulin resistance
  by activating several serine/threonine kinases, including protein kinase C (PKC),
  mammalian target of rapamycin (mTOR), c‐Jun N‐terminal kinase 1 (JNK1), IκB kinase
  (IKK), which inhibit insulin signaling either directly through insulin receptor
  substrate (IRS)‐1 and IRS‐2 serine phosphorylation or indirectly through a series
  of transcriptional events mediated by nuclear factor (NF)‐κB. This, in turn, results
  in reduced insulin activation of phosphatidylinositol (PI) 3‐kinase and Akt. Ceramide
  can also impair insulin action through interactions with Akt. Reduced Akt activation
  resulting in lower fork‐head box (FOX)O phosphorylation leads to increases in the
  transcription of phosphoenolpyruvate carboxycarboxykinase (PEPCK) and glucose‐6‐phosphatase
  (G6Pase). This enhances gluconeogenesis and hepatic glucose output (adapted from
  Nagle et al.). Copyright 2009 The American Society for Biochemistry and Molecular
  Biology.
pmcid: PMC4014913
papertitle: Molecular mechanisms involved in hepatic steatosis and insulin resistance.
reftext: Takashi Matsuzaka, et al. J Diabetes Investig. 2011 Jun 5;2(3):170-175.
pmc_ranked_result_index: '14036'
pathway_score: 0.9792138
filename: jdi-2-170-g2.jpg
figtitle: Metabolic pathways of fatty acid (FA) and triacylglycerol (TAG) synthesis,
  and mechanisms by which lipid intermediates affect hepatic insulin sensitivity
year: '2011'
organisms: Homo sapiens
ndex: c7019a0a-deb1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4014913__jdi-2-170-g2.html
  '@type': Dataset
  description: Metabolic pathways of fatty acid (FA) and triacylglycerol (TAG) synthesis,
    and mechanisms by which lipid intermediates affect hepatic insulin sensitivity.
    Excess lipid intermediates in the TAG biosynthetic pathway, such as diacylglycerol
    (DAG), phosphatidic acid (PA) and lysophosphatidic acid (LPA), cause insulin resistance
    by activating several serine/threonine kinases, including protein kinase C (PKC),
    mammalian target of rapamycin (mTOR), c‐Jun N‐terminal kinase 1 (JNK1), IκB kinase
    (IKK), which inhibit insulin signaling either directly through insulin receptor
    substrate (IRS)‐1 and IRS‐2 serine phosphorylation or indirectly through a series
    of transcriptional events mediated by nuclear factor (NF)‐κB. This, in turn, results
    in reduced insulin activation of phosphatidylinositol (PI) 3‐kinase and Akt. Ceramide
    can also impair insulin action through interactions with Akt. Reduced Akt activation
    resulting in lower fork‐head box (FOX)O phosphorylation leads to increases in
    the transcription of phosphoenolpyruvate carboxycarboxykinase (PEPCK) and glucose‐6‐phosphatase
    (G6Pase). This enhances gluconeogenesis and hepatic glucose output (adapted from
    Nagle et al.). Copyright 2009 The American Society for Biochemistry and Molecular
    Biology.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - REG3A
  - REL
  - MAPK8
  - AKT3
  - ELOVL6
  - RELA
  - LPA
  - NFKB1
  - PCK2
  - ACLY
  - NFKB2
  - SLC2A2
  - MAPK9
  - FOXO4
  - PPAT
  - MAPK10
  - DGAT1
  - IRS2
  - FAS
  - MTOR
  - FOXO1
  - ACACA
  - FOXO3
  - RELB
  - IRS1
  - ACACB
  - FOXO6
  - Ceramide
  - Glucose
  - Pyruvate
  - Serine
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PAP
  symbol: PAP
  source: hgnc_prev_symbol
  hgnc_symbol: REG3A
  entrez: '5068'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: JNK,NFKB
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ELOVL6
  symbol: ELOVL6
  source: hgnc_symbol
  hgnc_symbol: ELOVL6
  entrez: '79071'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PEPCK
  symbol: PEPCK
  source: hgnc_alias_symbol
  hgnc_symbol: PCK2
  entrez: '5106'
- word: ACL
  symbol: ACL
  source: hgnc_alias_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: GLUT-2
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: JNK,NFKB
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: GPAT
  symbol: GPAT
  source: hgnc_alias_symbol
  hgnc_symbol: PPAT
  entrez: '5471'
- word: JNK,NFKB
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: DGAT
  symbol: DGAT
  source: hgnc_prev_symbol
  hgnc_symbol: DGAT1
  entrez: '8694'
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
- word: Glucose
  source: MESH
  identifier: D005947
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Serine
  source: MESH
  identifier: D012694
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
